HER2/Neu Positive Active Not Recruiting Phase 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01273610Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerTreatment